Acebutolol
The risk or severity of adverse effects can be increased when Mannitol is combined with Acebutolol.
Acemetacin
The therapeutic efficacy of Mannitol can be decreased when used in combination with Acemetacin.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mannitol.
Advertisement
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Mannitol.
Aliskiren
The risk or severity of adverse effects can be increased when Mannitol is combined with Aliskiren.
Alphaprodine
The risk or severity of adverse effects can be increased when Alphaprodine is combined with Mannitol.
Advertisement
Amifostine
The risk or severity of adverse effects can be increased when Amifostine is combined with Mannitol.
Amifostine Anhydrous
The risk or severity of adverse effects can be increased when Amifostine is combined with Mannitol.
Amikacin
Mannitol may increase the nephrotoxic activities of Amikacin.
Advertisement
Amiloride
The risk or severity of adverse effects can be increased when Amiloride is combined with Mannitol.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Mannitol.
Amlodipine
The risk or severity of adverse effects can be increased when Amlodipine is combined with Mannitol.
Amobarbital
Amobarbital may increase the hypotensive activities of Mannitol.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Mannitol.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Mannitol.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Mannitol is combined with Amyl Nitrite.
Apalutamide
The serum concentration of Mannitol can be decreased when it is combined with Apalutamide.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Mannitol.
Apraclonidine
The risk or severity of adverse effects can be increased when Mannitol is combined with Apraclonidine.
Arbekacin
Mannitol may increase the nephrotoxic activities of Arbekacin.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Mannitol.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Mannitol.
Atenolol
The risk or severity of adverse effects can be increased when Atenolol is combined with Mannitol.
Azilsartan
The risk or severity of adverse effects can be increased when Mannitol is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Mannitol is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Mannitol is combined with Azilsartan medoxomil.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Mannitol.
Barbital
Barbital may increase the hypotensive activities of Mannitol.
Benazepril
The risk or severity of adverse effects can be increased when Benazepril is combined with Mannitol.
Bendroflumethiazide
The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Mannitol.
Bepridil
The risk or severity of adverse effects can be increased when Bepridil is combined with Mannitol.
Betaxolol
The risk or severity of adverse effects can be increased when Betaxolol is combined with Mannitol.
Bisoprolol
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Mannitol.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Mannitol.
Bretylium
The risk or severity of adverse effects can be increased when Mannitol is combined with Bretylium.
Brimonidine
The risk or severity of adverse effects can be increased when Brimonidine is combined with Mannitol.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Mannitol.
Bumetanide
The risk or severity of adverse effects can be increased when Mannitol is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Mannitol.
Buprenorphine
The risk or severity of adverse effects can be increased when Buprenorphine is combined with Mannitol.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Mannitol.
Canagliflozin
The risk or severity of adverse effects can be increased when Mannitol is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Mannitol is combined with Canagliflozin.
Candesartan Cilexetil
The risk or severity of hypotension can be increased when Candesartan cilexetil is combined with Mannitol.
Captopril
The risk or severity of adverse effects can be increased when Mannitol is combined with Captopril.
Carteolol
The risk or severity of adverse effects can be increased when Carteolol is combined with Mannitol.
Carvedilol
The risk or severity of adverse effects can be increased when Mannitol is combined with Carvedilol.
Chlorothiazide
The risk or severity of adverse effects can be increased when Mannitol is combined with Chlorothiazide.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Mannitol.
Chlorthalidone
The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Mannitol.
Cilazapril
The risk or severity of adverse effects can be increased when Mannitol is combined with Cilazapril.
Clevidipine
The risk or severity of adverse effects can be increased when Mannitol is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Mannitol is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Mannitol.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Mannitol.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Mannitol.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Mannitol.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Mannitol.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Mannitol.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Mannitol.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Mannitol.
Dapagliflozin
The risk or severity of adverse effects can be increased when Mannitol is combined with Dapagliflozin.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Mannitol.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Mannitol.
Dextromoramide
The risk or severity of adverse effects can be increased when Dextromoramide is combined with Mannitol.
Dezocine
The risk or severity of adverse effects can be increased when Dezocine is combined with Mannitol.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Mannitol is combined with Diclofenamide.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Mannitol.
Dihydrostreptomycin
Mannitol may increase the nephrotoxic activities of Dihydrostreptomycin.
Diltiazem
The risk or severity of adverse effects can be increased when Diltiazem is combined with Mannitol.
Dinutuximab
The risk or severity of adverse effects can be increased when Mannitol is combined with Dinutuximab.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Mannitol.
Dipyridamole
The risk or severity of adverse effects can be increased when Mannitol is combined with Dipyridamole.
Doxazosin
The risk or severity of adverse effects can be increased when Doxazosin is combined with Mannitol.
Duloxetine
Mannitol may increase the orthostatic hypotensive activities of Duloxetine.
Empagliflozin
The risk or severity of adverse effects can be increased when Mannitol is combined with Empagliflozin.
Enalapril
The risk or severity of adverse effects can be increased when Enalapril is combined with Mannitol.
Enalaprilat
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Mannitol.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Mannitol.
Eplerenone
The risk or severity of adverse effects can be increased when Eplerenone is combined with Mannitol.
Epoprostenol
The risk or severity of adverse effects can be increased when Epoprostenol is combined with Mannitol.
Eprosartan
The risk or severity of adverse effects can be increased when Mannitol is combined with Eprosartan.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Mannitol.
Ethacrynate
The risk or severity of adverse effects can be increased when Mannitol is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Mannitol is combined with Etacrynic acid.
Ethylmorphine
The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Mannitol.
Felodipine
The risk or severity of adverse effects can be increased when Mannitol is combined with Felodipine.
Fenoldopam
The risk or severity of adverse effects can be increased when Fenoldopam is combined with Mannitol.
Fentanyl
The risk or severity of adverse effects can be increased when Fentanyl is combined with Mannitol.
Fosinopril
The risk or severity of adverse effects can be increased when Fosinopril is combined with Mannitol.
Framycetin
Mannitol may increase the nephrotoxic activities of Framycetin.
Furosemide
The risk or severity of adverse effects can be increased when Furosemide is combined with Mannitol.
Gentamicin
Mannitol may increase the nephrotoxic activities of Gentamicin.
Guanfacine
The risk or severity of adverse effects can be increased when Mannitol is combined with Guanfacine.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Mannitol.
Heroin
The risk or severity of adverse effects can be increased when Heroin is combined with Mannitol.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Mannitol.
Hydralazine
The risk or severity of adverse effects can be increased when Mannitol is combined with Hydralazine.
Hydrochlorothiazide
The risk or severity of adverse effects can be increased when Mannitol is combined with Hydrochlorothiazide.
Hydrocodone
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Mannitol.
HYDROCODONE POLISTIREX
The risk or severity of adverse effects can be increased when Hydrocodone is combined with Mannitol.
Hydroflumethiazide
The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Mannitol.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Mannitol.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Mannitol.
Imidapril
The risk or severity of adverse effects can be increased when Imidapril is combined with Mannitol.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Mannitol.
Indapamide
The risk or severity of adverse effects can be increased when Mannitol is combined with Indapamide.
Indoramin
The risk or severity of adverse effects can be increased when Indoramin is combined with Mannitol.
Irbesartan
The risk or severity of adverse effects can be increased when Mannitol is combined with Irbesartan.
Isavuconazole
The serum concentration of Mannitol can be increased when it is combined with Isavuconazole.
Isocarboxazid
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Mannitol.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Mannitol.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Mannitol is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Mannitol is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Mannitol is combined with Isoxsuprine.
Isradipine
The risk or severity of adverse effects can be increased when Isradipine is combined with Mannitol.
Kanamycin
Mannitol may increase the nephrotoxic activities of Kanamycin.
kanamycin A
Mannitol may increase the nephrotoxic activities of Kanamycin.
Labetalol
The risk or severity of adverse effects can be increased when Labetalol is combined with Mannitol.
Lacidipine
Mannitol may increase the hypotensive activities of Lacidipine.
Lercanidipine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Mannitol.
Levobunolol
The risk or severity of adverse effects can be increased when Mannitol is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Mannitol.
Levodopa
Mannitol may increase the orthostatic hypotensive activities of Levodopa.
Levomethadyl
The risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Mannitol.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Mannitol.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Mannitol.
Lisinopril
The risk or severity of adverse effects can be increased when Lisinopril is combined with Mannitol.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Lisinopril is combined with Mannitol.
Lofexidine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Mannitol.
Losartan
The risk or severity of adverse effects can be increased when Losartan is combined with Mannitol.
Lumacaftor
The serum concentration of Mannitol can be decreased when it is combined with Lumacaftor.
Mecamylamine
The risk or severity of adverse effects can be increased when Mecamylamine is combined with Mannitol.
Meperidine
The risk or severity of adverse effects can be increased when Pethidine is combined with Mannitol.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Mannitol.
Mepirodipine
The risk or severity of adverse effects can be increased when Barnidipine is combined with Mannitol.
Methadone
The risk or severity of adverse effects can be increased when Methadone is combined with Mannitol.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Mannitol.
Methazolamide
The risk or severity of adverse effects can be increased when Methazolamide is combined with Mannitol.
Methohexital
Methohexital may increase the hypotensive activities of Mannitol.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Mannitol.
Methyldopa
The risk or severity of adverse effects can be increased when Mannitol is combined with Methyldopa.
METHYLDOPA ANHYDROUS
The risk or severity of adverse effects can be increased when Mannitol is combined with Methyldopa.
Metipranolol
The risk or severity of adverse effects can be increased when Mannitol is combined with Metipranolol.
Metolazone
The risk or severity of adverse effects can be increased when Metolazone is combined with Mannitol.
Metoprolol
The risk or severity of adverse effects can be increased when Metoprolol is combined with Mannitol.
Minoxidil
The risk or severity of adverse effects can be increased when Minoxidil is combined with Mannitol.
Moexipril
The risk or severity of adverse effects can be increased when Moexipril is combined with Mannitol.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Mannitol.
Moxonidine
The risk or severity of adverse effects can be increased when Moxonidine is combined with Mannitol.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Mannitol.
Nadolol
The risk or severity of adverse effects can be increased when Mannitol is combined with Nadolol.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Mannitol.
Nebivolol
The risk or severity of adverse effects can be increased when Mannitol is combined with Nebivolol.
Neomycin
Mannitol may increase the nephrotoxic activities of Neomycin.
Nesiritide
The risk or severity of adverse effects can be increased when Mannitol is combined with Nesiritide.
Netilmicin
Mannitol may increase the nephrotoxic activities of Netilmicin.
Nicardipine
The risk or severity of adverse effects can be increased when Nicardipine is combined with Mannitol.
Nicorandil
Nicorandil may increase the hypotensive activities of Mannitol.
Nifedipine
The risk or severity of adverse effects can be increased when Mannitol is combined with Nifedipine.
Nilvadipine
The risk or severity of adverse effects can be increased when Nilvadipine is combined with Mannitol.
Nimodipine
The risk or severity of adverse effects can be increased when Nimodipine is combined with Mannitol.
Nisoldipine
The risk or severity of adverse effects can be increased when Nisoldipine is combined with Mannitol.
Nitrendipine
The risk or severity of adverse effects can be increased when Nitrendipine is combined with Mannitol.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Mannitol.
Nitroglycerin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Mannitol.
Nitroprusside
The risk or severity of adverse effects can be increased when Nitroprusside is combined with Mannitol.
Normethadone
The risk or severity of adverse effects can be increased when Normethadone is combined with Mannitol.
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Mannitol.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Mannitol.
Opium
The risk or severity of adverse effects can be increased when Opium is combined with Mannitol.
Oxprenolol
The risk or severity of adverse effects can be increased when Oxprenolol is combined with Mannitol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Mannitol.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Mannitol.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Mannitol.
Papaverine
The risk or severity of adverse effects can be increased when Mannitol is combined with Papaverine.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Mannitol.
Paromomycin
Mannitol may increase the nephrotoxic activities of Paromomycin.
Penbutolol
The risk or severity of adverse effects can be increased when Mannitol is combined with Penbutolol.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Mannitol.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Mannitol.
Perindopril
The risk or severity of adverse effects can be increased when Mannitol is combined with Perindopril.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Mannitol.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Mannitol.
Phenoxybenzamine
The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Mannitol.
Phentolamine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Mannitol.
Phentolamine Mesylate
The risk or severity of adverse effects can be increased when Phentolamine is combined with Mannitol.
Pindolol
The risk or severity of adverse effects can be increased when Mannitol is combined with Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Mannitol.
Pirinitramide
The risk or severity of adverse effects can be increased when Piritramide is combined with Mannitol.
Plazomicin
Mannitol may increase the nephrotoxic activities of Plazomicin.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Mannitol.
Prazosin
The risk or severity of adverse effects can be increased when Prazosin is combined with Mannitol.
Primidone
Primidone may increase the hypotensive activities of Mannitol.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Mannitol.
Propoxyphene
The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Mannitol.
Propranolol
The risk or severity of adverse effects can be increased when Propranolol is combined with Mannitol.
Quetiapine
The risk or severity of adverse effects can be increased when Mannitol is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Mannitol is combined with Quetiapine.
Quinapril
The risk or severity of adverse effects can be increased when Mannitol is combined with Quinapril.
Ramipril
The risk or severity of adverse effects can be increased when Ramipril is combined with Mannitol.
Ranolazine
The serum concentration of Mannitol can be increased when it is combined with Ranolazine.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Mannitol.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Mannitol.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Mannitol.
Riociguat
The risk or severity of adverse effects can be increased when Mannitol is combined with Riociguat.
Risperidone
Mannitol may increase the hypotensive activities of Risperidone.
Ropinirole
The risk or severity of adverse effects can be increased when Ropinirole is combined with Mannitol.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Mannitol.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Mannitol.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Mannitol.
Secobarbital
Secobarbital may increase the hypotensive activities of Mannitol.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Mannitol.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Mannitol.
Sisomicin
Mannitol may increase the nephrotoxic activities of Sisomicin.
Sodium Phosphate
Mannitol may increase the nephrotoxic activities of Sodium phosphate.
Sodium Phosphate, Monobasic
Mannitol may increase the nephrotoxic activities of Sodium phosphate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Mannitol may increase the nephrotoxic activities of Sodium phosphate.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Mannitol.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Mannitol.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Mannitol.
Streptomycin
Mannitol may increase the nephrotoxic activities of Streptomycin.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Mannitol.
Tamsulosin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Mannitol.
Tapentadol
The risk or severity of adverse effects can be increased when Tapentadol is combined with Mannitol.
Telmisartan
The risk or severity of adverse effects can be increased when Mannitol is combined with Telmisartan.
Terazosin
The risk or severity of adverse effects can be increased when Mannitol is combined with Terazosin.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Mannitol.
Thiamylal
Thiamylal may increase the hypotensive activities of Mannitol.
Thiopental
Thiopental may increase the hypotensive activities of Mannitol.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Mannitol.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Mannitol.
Timolol
The risk or severity of adverse effects can be increased when Timolol is combined with Mannitol.
Timolol Anhydrous
The risk or severity of adverse effects can be increased when Timolol is combined with Mannitol.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Mannitol.
Tobramycin
Mannitol may increase the nephrotoxic activities of Tobramycin.
Tolazoline
The risk or severity of adverse effects can be increased when Tolazoline is combined with Mannitol.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Mannitol.
Torsemide
The risk or severity of adverse effects can be increased when Torasemide is combined with Mannitol.
Tramadol
The risk or severity of adverse effects can be increased when Tramadol is combined with Mannitol.
Trandolapril
The risk or severity of adverse effects can be increased when Trandolapril is combined with Mannitol.
Tranylcypromine
The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Mannitol.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Mannitol.
Triamterene
The risk or severity of adverse effects can be increased when Triamterene is combined with Mannitol.
Valsartan
The risk or severity of adverse effects can be increased when Valsartan is combined with Mannitol.
Vemurafenib
The serum concentration of Mannitol can be increased when it is combined with Vemurafenib.
Verapamil
The risk or severity of adverse effects can be increased when Verapamil is combined with Mannitol.
